In comparison, there were no obvious associations between the expression levels of ABHD2, FGF2, DCAF7, GSK3B, NACC2, DICER1, and FGFR1OP genes and survival rate in prostate cancer patients. This evidence concerns the gene NACC2 and prostate carcinoma.